Visual field analysis in patients with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 14, Issue 3, 2008, Pages 193-198

  Yenice, Ozlem ^a   Onal, Sumru ^a   Midi, Ipek ^a   Ozcan, Eda ^a   Temel, Ahmet ^a   I Gunal, Dilek ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Glaucoma like visual field defects; Neurodegenerative diseases; Parkinson's disease

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; MALE; PARKINSON DISEASE; PERIMETRY; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL FIELD; VISUAL FIELD DEFECT;

AGED; FEMALE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; VISUAL FIELDS;

EID: 41449114244     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.07.018     Document Type: Article

References (27)

1. Kerrigan L.A., Zack D.J., Quigley H.A., Smith S.D., and Pease M.E. TUNEL-positive ganglion cells in human primary open angle glaucoma. Arch Ophthalmol 115 (1997) 1031-1035
2. Garcia-Valenzuela E., Shareef S., Walsh J., and Sharma S.C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61 (1995) 33-44
3. McKinnon S.J. Glaucoma, apoptosis, and neuroprotection. Curr Opin Ophthalmol 8 (1997) 28-37
4. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 56 (1999) 33-39
5. Fahn S, Elton R. Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent Developments in Parkinson's Disease, Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987, p. 153-163, 293-304.
6. Tatton W.G., Chalmers-Redman R.M., Ju W.Y., Chalmers-Redman R.M., and Tatton N.A. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J Neural Transm Suppl 49 (1997) 245-268
7. Lev N., Melamed E., and Offen D. Apoptosis and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 245-250
8. Nagatsu T., Mogi M., Ichinose H., and Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl 60 (2000) 277-290
9. Chauhan N.B., Siegel G.J., and Lee J.M. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain. J Chem Neuroanat 21 (2001) 277-288
10. Mitchell I.J., Lawson S., Moser B., Laidlaw S.M., Cooper A.J., Walkinshaw G., et al. Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat. Neuroscience 63 (1994) 1-5
11. Dreyer E.B., Zurakowski D., Schumer R.A., Podos S.M., and Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114 (1996) 299-305
12. Hare W., WoldeMussie E., Lai R., Ton H., Ruiz G., Feldmann B., et al. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv Ophthalmol 45 Suppl. 3 (2001) 284-289
13. Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., and Zack D.J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 41 (2000) 764-774
14. Peppe A., Stanzione P., Pierelli F., De Angelis D., Pierantozzi M., and Bernardi G. Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology 45 (1995) 1144-1148
15. Stanzione P., Pierantozzi M., Semprini R., Tagliati M., Traversa R., Peppe A., et al. Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram. Vision Res 35 (1995) 2659-2664
16. Buttner T., Kuhn W., Muller T., Heinze T., Puhl C., and Przuntek H. Chromatic and achromatic visual evoked potentials in Parkinson's disease. Electroencephalogr Clin Neurophysiol 100 (1996) 443-447
17. Sartucci F., Orlandi G., Lucetti C., Bonuccelli U., Murri L., Orsini C., et al. Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease. J Clin Neurophysiol 20 (2003) 375-381
18. Sartucci F., Orlandi G., Bonuccelli U., Borghetti L., Murri L., Orsini C., et al. Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease. Neurol Sci 26 (2006) 395-401
19. Dowling J.E. Functional and pharmacological organization of the retina: dopamine, interplexiform cells, and neuromodulation. In: Cohen B., and Bodis-Wollner I. (Eds). Vision and the brain: the organization of the central visual system (1990), Raven Press, New York
20. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci 13 (1990) 296-302
21. Nguyen-Legros J. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat 10 (1988) 137-144
22. Tagliati M., Bodis-Wollner I., Kovanecz I., and Stanzione P. Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine. Vision Res 34 (1994) 2051-2057
23. Ghilardi M.F., Bodis-Wollner I., Onofrj M.C., Marx M.S., and Glover A.A. Spatial frequency dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain 111 (1988) 131-149
24. Inzelberg R., Ramirez J.A., Nisipeanu P., and Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 44 (2004) 2793-2797
25. Johnson C.A., Adams A.J., Casson E.J., and Brandt J.D. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol 111 (1993) 651-656
26. Bengtsson B., and Heijl A. Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma: a comparison between different test programs. Ophthalmology 113 (2006) 1092-1097
27. Bayer A.U., Keller O.N., Ferrari F., and Maag K.P. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 133 (2002) 135-137